News from NORD

NCATS Unveils Toolkit for Patient-Focused Therapy Development

Publish date: August 7, 2018

 

The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has developed a new toolkit for the rare disease community to facilitate therapeutics research and development. Learn more about the toolkit here.

Recommended Reading

Surgical Procedures for Hidradenitis Suppurativa
MDedge Dermatology
Oral drug seen preventing angioedema attacks
MDedge Dermatology
Study offers snapshot of esophageal strictures in EB patients
MDedge Dermatology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Dermatology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Dermatology
RFPs Available for the Study of Three Rare Diseases
MDedge Dermatology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Dermatology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Dermatology
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
MDedge Dermatology
Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients
MDedge Dermatology